Facebook
Instagram
Linkedin
Youtube
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Search
BioStock
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Home
Tags
Tumour recurrence
Tag: tumour recurrence
Mendus presents proof-of-concept data in AML maintenance
13 December, 2022
Mendus nears late-stage development with cancer relapse vaccine
24 October, 2022
Mendus in strong position for clinical progress
1 September, 2022
Immunicum changes name to Mendus
1 July, 2022
Immunicum delivers positive phase II data in AML
19 May, 2022
Immunicum to present data for potential AML treatment
6 May, 2022
Immunicum participates in new cancer research consortium
21 April, 2022
Immunicum’s strategy for fighting tumour recurrence
23 March, 2022
Immunicum publishes DCP-001 data
26 November, 2021
BioStock Studio: Immunicum’s CEO on the company’s new therapeutic focus
13 September, 2021